We presently review the effects of PTGS2/COX2-PGE2 cascade in different inflammatory contexts, focusing on pancreatic beta cells subjected to T1DM conditions and discuss its potential exploitation as therapeutic target for the autoimmune pathology. This evidence concerns the gene PTGER2 and type 1 diabetes mellitus.